Quality management benchmarking: FDA compliance in pharmaceutical industry

Abstract

Purpose

By analyzing and comparing industry and business best practice, processes can be optimized and become more successful mainly because efficiency and competitiveness increase. This paper aims to focus on some examples.

Design/methodology/approach

Case studies are used to show knowledge exchange in the pharmaceutical industry. Best practice solutions were identified in two companies using a benchmarking method and five‐stage model.

Findings

Despite large administrations, there is much potential regarding business process organization. This project makes it possible for participants to fully understand their business processes. The benchmarking method gives an opportunity to critically analyze value chains (a string of companies or players working together to satisfy market demands for a special product).

Practical implications

Knowledge exchange is interesting for companies that like to be global players. Benchmarking supports information exchange and improves competitive ability between different enterprises. Findings suggest that the five‐stage model improves efficiency and effectiveness. Furthermore, the model increases the chances for reaching targets. The method gives security to partners that did not have benchmarking experience.

Originality/value

The study identifies new quality management procedures. Process management and especially benchmarking is shown to support pharmaceutical industry improvements.

Citation

Jochem, R. and Landgraf, K. (2010), "Quality management benchmarking: FDA compliance in pharmaceutical industry", International Journal of Health Care Quality Assurance, Vol. 23 No. 8, pp. 690-698. https://doi.org/10.1108/09526861011081813